Literature DB >> 2830545

Modulation of brain alpha 2-adrenoceptor and mu-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats.

I Ulibarri1, J A García-Sevilla, L Ugedo.   

Abstract

The densities of brain alpha 2-adrenoceptors and mu-opioid receptors, quantitated by means of the binding of the agonists [3H]clonidine and [3H]dihydromorphine, respectively, were studied during the development of morphine dependence and spontaneous withdrawal in the rat. The oral administration of morphine (12-130 mg/kg for 3-21 days) led to inconsistent changes in alpha 2-adrenoceptor density while the density of mu-opioid receptors was down-regulated. In contrast, spontaneous opiate withdrawal (3-72 h) significantly increased the density of alpha 2-adrenoceptors while the density of mu-opioid receptors was rapidly up-regulated to control values. In the hypothalamus, but not in other brain regions, the increase in alpha 2-adrenoceptor density after withdrawal followed a time course (3-72 h) related to the severity of the abstinence syndrome. Thus, there was a positive and significant correlation between the severity of withdrawal and the density of alpha 2-adrenoceptors in the hypothalamus. Short-term treatment with clonidine (2 x 0.5 mg/kg, i.p.) prevented the morphine withdrawal-induced increases in alpha 2-adrenoceptor density in various brain regions, but not in the hypothalamus. The main results suggest that modulation of hypothalamic alpha 2-adrenoceptor density during morphine withdrawal is a relevant physiological mechanism by which the opiate abstinence syndrome is counteracted.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2830545     DOI: 10.1007/BF00169310

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  The addiction cycle to narcotics in the rat and its relation to catecholamines.

Authors:  T Akera; T M Brody
Journal:  Biochem Pharmacol       Date:  1968-05       Impact factor: 5.858

2.  Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates.

Authors:  N Brunello; A Volterra; A M Di Giulio; V Cuomo; G Racagni
Journal:  Life Sci       Date:  1984-04-23       Impact factor: 5.037

3.  Labelling of human platelet alpha 2-adrenoceptors with the full agonist [3H](-)adrenaline.

Authors:  J A Garcia-Sevilla; M J Fuster
Journal:  Eur J Pharmacol       Date:  1986-05-13       Impact factor: 4.432

4.  Effects of alpha 2-agonists on morphine withdrawal behaviour: potentiation of jumping mediated by alpha 2-receptors.

Authors:  J W van der Laan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

5.  Biochemical correlates of morphine withdrawal. 1. Characterization in the adrenal medulla and locus ceruleus.

Authors:  P S DiStefano; O M Brown
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

6.  Brain catecholamine metabolites and behavior in morphine withdrawal.

Authors:  A C Swann; J D Elsworth; D S Charney; D M Jablons; R H Roth; D E Redmond; J W Maas
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

7.  Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.

Authors:  D S Charney; D E Redmond; M P Galloway; H D Kleber; G R Heninger; M Murberg; R H Roth
Journal:  Life Sci       Date:  1984-09-17       Impact factor: 5.037

8.  Opiate and alpha 2-adrenoceptor responses of rat amygdaloid neurons: co-localization and interactions during withdrawal.

Authors:  J E Freedman; G K Aghajanian
Journal:  J Neurosci       Date:  1985-11       Impact factor: 6.167

9.  Biochemical correlates of morphine withdrawal. 2. Effects of clonidine.

Authors:  P S DiStefano; O M Brown
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

10.  alpha 2-Adrenoreceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment.

Authors:  C B Smith; J A Garcia-Sevilla; P J Hollingsworth
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

View more
  9 in total

1.  Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.

Authors:  Katharine M Seip-Cammack; Brian Reed; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2012-07-25       Impact factor: 4.530

2.  Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.

Authors:  C Ribas; A Miralles; X Busquets; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain.

Authors:  M A Boronat; M J García-Fuster; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 4.  Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics.

Authors:  Laura Albizu; José L Moreno; Javier González-Maeso; Stuart C Sealfon
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

5.  Chronic infusion of clonidine does not alleviate spontaneous morphine withdrawal symptoms in rats.

Authors:  J W van der Laan; C Jansen van't Land
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

7.  Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.

Authors:  Markus Kathmann; Karsten Flau; Agnes Redmer; Christian Tränkle; Eberhard Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-18       Impact factor: 3.000

8.  Effect of morphine and abstinence syndrome on [3H]bromoxidine binding to alpha 2-adrenoceptors in rat brain.

Authors:  A Fernández-López; C Soria; V Revilla; T Gómez; P Calvo
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

9.  mu-Opioid receptor and alpha 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts.

Authors:  A M Gabilondo; J J Meana; F Barturen; M Sastre; J A García-Sevilla
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.